Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Switzerland
/
Healthcare
/
Straumann Holding
STMN
Straumann Holding
Emerging Markets And Aging Populations Will Redefine Dental Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
08 Jun 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
CHF 148.00
34.3% undervalued
intrinsic discount
15 Aug
CHF 97.26
Loading
1Y
-22.8%
7D
-6.1%
Author's Valuation
CHF 148.0
34.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
CHF 148.0
34.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
4b
2014
2017
2020
2023
2025
2026
2028
Revenue CHF 3.6b
Earnings CHF 828.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.35%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
4.51%
Calculation
CHF 828.94m
Earnings '28
x
32.82x
PE Ratio '28
=
CHF 27.21b
Market Cap '28
CHF 27.21b
Market Cap '28
/
160.94m
No. shares '28
=
CHF 169.05
Share Price '28
CHF 169.05
Share Price '28
Discounted to 2025 @ 4.52% p.a.
=
CHF 148.06
Fair Value '25